Topic of the lesson: Chromosomal disorders
The 'combined test' (nuchal translucency, beta-human chorionic gonadotrophin (β-HCG) and pregnancy-associated plasma protein-A) should be the screening test offered to women between 11 weeks 0 days and 13 weeks 6 days. For women who book later, triple or quadruple test) should be offered between 15 weeks 0 days and 20 weeks 0 days. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- autoimmune disorders of the blood
- autoimmune disorders of the mouth
- autoimmune disorders of the skin
- autoimmune disorders of the muscles
- blistering disorders of the skin
- disorders of the joints
- disorders of the nervous system list
- disorders of the brain
- neurological disorders of the brain
- autoimmune disorders of the brain
- degenerative disorders of the brain
- disorders of the cerebellum